Novo Nordisk stock soar 5% today: here’s why analysts are bullish

Novo Nordisk stock jumped about 5% in pre-market trading, boosted by good news around its obesity drug Wegovy. The FDA has just cleared the drug for use in treating alcoholic steatohepatitis (ASH), a serious liver disease. That approval broadens Wegovy’s reach well beyond its existing role in weight loss and obesity care, opening up a […]